Subscribe to RSS

DOI: 10.1055/s-0045-1811546
Efficacy and Safety of Endoscopic Gastroplasty versus Lifestyle Modification for Obesity: A Meta-Analysis of Randomized Controlled Trials with Technique-Specific Subgroup Analysis
Authors
Funding None.

Abstract
Background
Endoscopic gastroplasty (EG) offers a minimally invasive alternative to bariatric surgery for obesity management. While multiple randomized controlled trials (RCTs) have compared EG with lifestyle modification (LM), the extent of benefit and influence of procedural technique remain uncertain.
Materials and Methods
We conducted a meta-analysis restricted to RCTs comparing EG with LM in adults with obesity. The primary outcome was total body weight loss (TBWL) at 12 months. Secondary outcomes included TBWL and excess weight loss (EWL) at 6 months, and EWL at 12 months. Pooled mean differences (MDs) were estimated using a random-effects model. Subgroup analyses were performed based on techniques, such as OverStitch ESG, Endomina, and Primary Obesity Surgery Endoluminal (POSE). Trial sequential analysis (TSA) and assessment of adverse events and publication bias were also conducted.
Results
Five RCTs involving 696 participants were included. EG resulted in significantly greater TBWL at 12 months compared to LM (MD: 7.67%; 95% confidence interval [CI]: 4.38–10.96; I 2 = 92.5%). TSA confirmed the conclusiveness of this finding. EG also led to superior TBWL at 6 months (MD: 6.98%; 95% CI: 3.76–10.20) and greater EWL at 6 months (MD: 24.85%; 95% CI: 13.44–36.27) and 12 months (MD: 26.24%; 95% CI: 11.19–41.29). Subgroup analysis showed highest efficacy with OverStitch ESG (MD: 10.82%), followed by Endomina (6.50%) and POSE (5.61%). The pooled incidence of any adverse event was 10.8%, while serious adverse events were rare (2.9%).
Conclusion
EG is more effective than LM for weight loss at 6 and 12 months, with an acceptable safety profile. Among techniques, OverStitch ESG demonstrated the highest efficacy. These findings support the incorporation of EG into the obesity treatment algorithm, especially for patients unsuitable for surgery.
Keywords
endoscopic gastroplasty - obesity treatment - lifestyle modification - randomized controlled trials - weight loss - OverStitch - Endomina - POSEAuthors' Contributions
Concept and design: N.J., R.K., D.N.R. Supervision: R.K., D.N.R. Resources: V.H., I.B., R.K. Data collection and/or processing: N.J., A.G., S.J. Analysis and interpretation: N.J., A.. Literature search: A.G., S.J. Writing – original draft: N.J., A.G. Writing – review and editing: S.J., I.B., V.H. Critical review and final approval: All authors.
Publication History
Article published online:
08 September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Sturgiss EA, Haesler E, Elmitt N, Douglas K. Obesity management in primary care. Lancet 2017; 389 (10079): 1605
- 2 Bray GA, Frühbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet 2016; 387 (10031): 1947-1956
- 3 Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol 2020; 75 (02) 235-251
- 4 Schauer PR, Bhatt DL, Kirwan JP. et al; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med 2017; 376 (07) 641-651
- 5 Lopez-Nava G, Sharaiha RZ, Vargas EJ. et al. Endoscopic sleeve gastroplasty for obesity: a multicenter study of 248 patients with 24 months follow-up. Obes Surg 2017; 27 (10) 2649-2655
- 6 Jagtap N, Kalapala R, Katakwar A. et al. Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity. Indian J Gastroenterol 2021; 40 (06) 572-579
- 7 Maydeo A, Patil G, Dalal A, Thakare S, Iyer A, Patil N. An Indian experience of endoscopic treatment of obesity by using a novel technique of endoscopic sleeve gastroplasty (accordion procedure). J Assoc Physicians India 2020; 68 (08) 14-17
- 8 Abad J, Llop E, Arias-Loste MT. et al. Endoscopic sleeve gastroplasty plus lifestyle intervention in patients with MASH: a multicentre, sham-controlled, randomized trial. Clin Gastroenterol Hepatol 2025; 23 (09) 1556-1566
- 9 Abu Dayyeh BK, Bazerbachi F, Vargas EJ. et al; MERIT Study Group. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet 2022; 400 (10350): 441-451
- 10 Sullivan S, Swain JM, Woodman G. et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity (Silver Spring) 2017; 25 (02) 294-301
- 11 Miller K, Turró R, Greve JW, Bakker CM, Buchwald JN, Espinós JC. Medical Therapy. MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose SM vs. medical therapy. Obes Surg 2017; 27 (02) 310-322
- 12 Huberty V, Boskoski I, Bove V. et al. Endoscopic sutured gastroplasty in addition to lifestyle modification: short-term efficacy in a controlled randomised trial. Gut 2020; gutjnl-2020- 322026
- 13 Chan KS, Ho S, Pang K. et al. Comparison of weight loss and improvement in metabolic comorbidities between endoscopic gastroplasty and lifestyle modifications: a meta-analysis. Surg Laparosc Endosc Percutan Tech 2025; 35 (03) e1361
- 14 Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 2008; 61 (01) 64-75
- 15 Lopez Nava G, Asokkumar R, Laster J. et al. Primary obesity surgery endoluminal (POSE-2) procedure for treatment of obesity in clinical practice. Endoscopy 2021; 53 (11) 1169-1173
- 16 Lopez Nava G, Arau RT, Asokkumar R. et al. Prospective multicenter study of the Primary Obesity Surgery Endoluminal (POSE 2.0) procedure for treatment of obesity. Clin Gastroenterol Hepatol 2023; 21 (01) 81-89.e4
- 17 Huberty V, Machytka E, Boškoski I, Barea M, Costamagna G, Deviere J. Endoscopic gastric reduction with an endoluminal suturing device: a multicenter prospective trial with 1-year follow-up. Endoscopy 2018; 50 (12) 1156-1162
- 18 Espinet Coll E, Nebreda Durán J, López-Nava Breviere G. et al. Multicenter study on the safety of bariatric endoscopy. Rev Esp Enferm Dig 2017; 109 (05) 350-357
- 19 Bhandari M, Kosta S, Reddy M, Mathur W, Neto MG, Bhandari M. Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India. J Minim Access Surg 2023; 19 (01) 101-106
- 20 Bhandari M, Jain S, Mathur W. et al. Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: first Indian experience. Dig Endosc 2020; 32 (04) 541-546